Alpha Crest Capital Management LLC Guardant Health, Inc. Transaction History

Alpha Crest Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $337,579 - $471,652	7,732 New	7,732 $416,000
Q4 2021 Feb 09, 2022	SELL	$88.71 - $120.43 $207,226 - $281,324	-2,336 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$98.77 - $132.17 $494,245 - $661,378	-5,004 Reduced 68.17%	2,336 $292,000
Q2 2021 Aug 12, 2021	BUY	$109.77 - $165.68 $465,424 - $702,483	4,240 Added 136.77%	7,340 $912,000
Q1 2021 May 13, 2021	SELL	$127.04 - $179.1 $266,784 - $376,110	-2,100 Reduced 40.38%	3,100 $473,000
Q4 2020 Feb 12, 2021	BUY	$99.96 - $135.93 $289,884 - $394,197	2,900 Added 126.09%	5,200 $670,000
Q3 2020 Nov 12, 2020	SELL	$80.32 - $111.8 $168,672 - $234,780	-2,100 Reduced 47.73%	2,300 $257,000
Q2 2020 Aug 12, 2020	BUY	$60.49 - $97.5 $266,156 - $429,000	4,400 New	4,400 $357,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.97B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.